Similarly, the suppression of mediator complex subunit 19 down-regulated autophagy by inhibiting HMGB1 signaling and enhanced doxorubicin chemosensitivity in human breast cancer cells [82]. This evidence concerns the gene HMGB1 and breast cancer.